Health Care & Life Sciences » Pharmaceuticals | Foamix Pharmaceuticals Ltd.

Foamix Pharmaceuticals Ltd. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,308.00
49,966.00
56,364.00
113,327.00
67,736.00
99,102
Total Accounts Receivable
557.00
690.00
439.00
3,428.00
1,180.00
1,615
Other Current Assets
30.00
235.00
346.00
246.00
588.00
450
Total Current Assets
2,895.00
50,891.00
57,149.00
117,001.00
69,504.00
101,167
Net Property, Plant & Equipment
62.00
248.00
646.00
938.00
2,042.00
2,235
Total Investments and Advances
-
104.00
47,415.00
17,661.00
8,676.00
283
Other Assets
129.00
34.00
35.00
35.00
32.00
46
Total Assets
3,086.00
51,277.00
105,245.00
135,635.00
80,254.00
103,731
ST Debt & Current Portion LT Debt
468.00
505.00
507.00
20.00
-
Accounts Payable
89.00
626.00
1,353.00
2,267.00
6,436.00
Other Current Liabilities
1,194.00
1,003.00
2,198.00
2,984.00
3,792.00
Total Current Liabilities
1,751.00
2,134.00
4,058.00
5,271.00
10,228.00
Long-Term Debt
4,549.00
51.00
20.00
-
-
Provision for Risks & Charges
-
330.00
365.00
379.00
437.00
Other Liabilities
368.00
-
-
-
988.00
Total Liabilities
6,668.00
2,515.00
4,443.00
5,650.00
11,653.00
Common Equity (Total)
3,582.00
48,762.00
100,802.00
129,985.00
68,601.00
Total Shareholders' Equity
3,582.00
48,762.00
100,802.00
129,985.00
68,601.00
Total Equity
3,582.00
48,762.00
100,802.00
129,985.00
68,601.00
Liabilities & Shareholders' Equity
3,086.00
51,277.00
105,245.00
135,635.00
80,254.00

About Foamix Pharmaceuticals

View Profile
Address
2 Holzman Street
Rehovot HM 76704
Israel
Employees -
Website http://www.foamixpharma.com
Updated 07/08/2019
Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.